현재가
Celgene Corporation (CELG-R) is a prominent biopharmaceutical firm specializing in innovative therapies for cancer and inflammatory disorders. Renowned for its robust research and development efforts, Celgene has signifi...|
e.g. Promoter holding
Loading chart...
애널리스트 컨센서스 기준 EPS 및 매출 전망.
해당 기업의 실적 전망 데이터가 없습니다.
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | AAbony Acqu... | AACOU | — | — | — | — | — | — | — |
| 2. | AApogee Acq... | AACPU | — | — | — | — | — | — | — |
| 3. | AAres Acqui... | AACTWS | — | — | — | — | — | — | — |
| 4. | AAres Acqui... | AAC-U | — | — | — | — | — | — | — |
| 5. | AAres Acqui... | AAC-WS | — | — | — | — | — | — | — |
연결 기준 (백만 단위) / 별도 보기 가능
| Quarter (M) |
|---|
Revenue |
COGS |
Gross Profit |
Gross Profit % |
EBIT |
OPM % |
Non-Operating Income |
PBT |
Income Tax |
Tax Rate % |
Net Income |
NPM % |
연결 기준 (백만 단위) / 별도 보기 가능
| Period (M) |
|---|
Revenue |
COGS |
Gross Profit |
Gross Profit % |
EBIT |
OPM % |
Non-Operating Income |
PBT |
Income Tax |
Tax Rate % |
Net Income |
NPM % |
연결 기준 (백만 단위) / 별도 보기 가능
| Period (M) |
|---|
Total Assets |
Total Liabilities |
연결 기준 (백만 단위) / 별도 보기 가능
| Period (M) |
|---|
Net CFNet Cash Flow |
FCFFree Cash Flow |
Financial ratios and valuation metrics by fiscal year.
| Period |
|---|
Cash Conversion |
Payout Ratio |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
BristolMyers Squibb Company. Contingent Value Rt 12312030의 주주 구성 (SEC 공시 기준)
이 회사의 SEC 지분 공시가 아직 없습니다.
BristolMyers Squibb Company. Contingent Value Rt 12312030의 SEC 공시 및 실적 발표 컨퍼런스콜 녹취록
이 회사의 SEC 공시가 아직 없습니다.
What recent news says about BristolMyers Squibb Company. Contingent Value Rt 12312030, scored for sentiment.